Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Control Intervention1: nil: nil
Sponsors
Amrita Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Thirty American Society of Anaesthesiologists physical status II patients between age group18-65 years and posted for breast cancer surgeries for breast cancer surgeries
Exclusion criteria
Exclusion criteria: Patients not consenting for epidural anaesthesia, anticoagulant drugs, psychiatric illness, allergy to local anaesthetic and local infection were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective was to evaluate the efficacy of thoracic epidural anaesthesia in providing complete opioid free surgical anaesthesia and postoperative analgesia for breast cancer surgeries. The efficacy of the anaesthetic will be assessed in terms of total number of cases that need to be converted to general anaesthesia.Timepoint: 20 minutes after epidural bolus administration | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome measures were the time to achieve complete surgical anaesthesia after placement of epidural catheter, haemodynamic instability, amount of ketamine used, pain scores in the postoperative period, patientsââ?¬â?¢ and surgeonsââ?¬â?¢ satisfaction score.Timepoint: Intraoperative period | — |
Countries
India
Contacts
Public ContactNitu PV
Amrita Institute of medical Sciences
Outcome results
None listed